Q39* (p.Gln39Ter) variant of NBN (Nibrin)
Q39* (p.Gln39Ter) in NBN (Nibrin) is a protein-truncating change. Clinical records from EBI and UniProt describe it as pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.56 / 1. The record also includes population frequency data, published literature, and structural context.
Q39* (p.Gln39Ter) variant details
- p.Gln39Ter
- rs377730553
- ClinGen CA371663153
- ClinVar RCV001186594
- ClinVar RCV001862938
- Pathogenic
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.561
- CADD 36.00
- EBI: Pathogenic
- UniProt: Pathogenic
- Most common in the Non-Finnish European population (allele frequency 2.7e-05)
- Structural context available
- Cited in: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic… (PMID 25394175)
- Cited in: Nijmegen Breakage Syndrome. (PMID 20301355)